Follow-up
After the two-stage ablations, all patients were discharged in sinus rhythm. No patient was lost during follow-up and all patients completed the 1-year follow-up. Four patients (n = 1 in BB group; n = 3 in CONV group) experienced early recurrences within the blanking period (<3 months). The 1-year success rate free of AAD was 96.6% in BB Group and 76.6% in the CONV group (p=0.025). A Kaplan–Meier curve of arrhythmia-free survival for both groups was reported in Figure 3. No deaths or thromboembolic events were recorded.
Quality of life questionnaire EQ-5D-3L was obtained from all patients. There was no statistically significant difference between groups (suppl. material).